Hitachi HD44780 LCD controller

Métis National Council Supportive of Budget 2024

Retrieved on: 
Tuesday, April 16, 2024

Ottawa, ON, April 16, 2024 (GLOBE NEWSWIRE) -- The Métis National Council (MNC) is pleased to see Budget 2024 include important investments in the Métis Nation.

Key Points: 
  • Ottawa, ON, April 16, 2024 (GLOBE NEWSWIRE) -- The Métis National Council (MNC) is pleased to see Budget 2024 include important investments in the Métis Nation.
  • The announcement of investment into the re-capitalization of Métis Capital Corporations is important news for Métis business-owners across the Homeland.
  • Although Budget 2024 does not fully address the pressing needs of Métis citizens and Governments across the Homeland, including in the areas of health and emergency management, the Métis National Council applauds Canada’s attentiveness to the needs and priorities for which the Métis Nation has been advocating.”
    For the Métis Nation, investments in self-determined health benefits, including dental care and pharmacare, are long overdue.
  • Since 1983, the Métis National Council has been the national and international voice of the Métis Nation within Canada.

NSSF PRAISES WYOMING GOV. MARK GORDON FOR PROTECTING SECOND AMENDMENT PRIVACY

Retrieved on: 
Monday, March 25, 2024

Mark Gordon for signing the NSSF-supported Second Amendment Financial Privacy Act, Senate File 105 .

Key Points: 
  • Mark Gordon for signing the NSSF-supported Second Amendment Financial Privacy Act, Senate File 105 .
  • This law protects the privacy and sensitive financial information of people purchasing firearms, firearm parts and ammunition in Wyoming.
  • "NSSF thanks Governor Gordon for signing the Second Amendment Financial Privacy Act to protect the rights and privacy of Wyoming citizens.
  • Wyoming joins Indiana, Utah, Florida, Idaho, Mississippi, Montana, North Dakota, Texas and West Virginia with laws protecting citizens' Second Amendment privacy.

EMI Shielding Market worth $9.4 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, November 28, 2023

The Conductive Coatings & Paints segment in EMI shielding are expected to dominate.

Key Points: 
  • The Conductive Coatings & Paints segment in EMI shielding are expected to dominate.
  • Conductive coatings and paints are a versatile solution for EMI shielding due to their ability to be applied to a wide range of materials and their high shielding capability.
  • These factors are contributing to their highest market share in the EMI shielding industry.
  • This extensive manufacturing base creates a high demand for EMI shielding solutions to protect these devices from electromagnetic interference.

EMI Shielding Market worth $9.4 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, November 28, 2023

The Conductive Coatings & Paints segment in EMI shielding are expected to dominate.

Key Points: 
  • The Conductive Coatings & Paints segment in EMI shielding are expected to dominate.
  • Conductive coatings and paints are a versatile solution for EMI shielding due to their ability to be applied to a wide range of materials and their high shielding capability.
  • These factors are contributing to their highest market share in the EMI shielding industry.
  • This extensive manufacturing base creates a high demand for EMI shielding solutions to protect these devices from electromagnetic interference.

AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023

Retrieved on: 
Monday, October 16, 2023

THOUSAND OAKS, Calif., Oct. 16, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of new data across its broad oncology portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress 2023, taking place from October 20-24 in Madrid. Results from Amgen-sponsored and collaborative studies, including two late-breaking oral presentations, will feature data in a range of tough-to-treat cancers.

Key Points: 
  • Results from Amgen-sponsored and collaborative studies, including two late-breaking oral presentations, will feature data in a range of tough-to-treat cancers.
  • "Our data at ESMO demonstrate the rapid progress we are making in advancing a portfolio with first-in-class therapies, including metastatic KRAS G12C mutated colorectal cancer and small cell lung cancer," said David M. Reese, M.D., executive vice president of Research and Development at Amgen.
  • "These findings illustrate how we are attacking cancer from many different angles to deliver new approaches poised to alter the natural history of disease across many cancers."
  • Amgen will present data from two late-breaking abstracts at ESMO:
    Results from CodeBreaK 300 (Abstract #LBA10), a global, registration-enabling Phase 3 trial evaluating LUMAKRAS (sotorasib) combined with Vectibix (panitumumab) in chemorefractory KRAS G12C-mutated metastatic CRC.

Finix Is Now A Payments Processor: Simplifying The Payments Stack for More Seamless Operations

Retrieved on: 
Tuesday, May 2, 2023

SAN FRANCISCO, May 2, 2023 /PRNewswire/ -- Today, Finix announced its launch as a payments processor. As a processor, Finix is directly connected to all major U.S. card networks—American Express, Discover, Mastercard, and Visa. This allows Finix to offer more businesses instant onboarding, innovative products, and streamlined payment operations.

Key Points: 
  • SAN FRANCISCO, May 2, 2023 /PRNewswire/ -- Today, Finix announced its launch as a payments processor.
  • This allows Finix to offer more businesses instant onboarding, innovative products, and streamlined payment operations.
  • We offer flexible, reliable technology that scales with businesses as they grow and as payments technology evolves," said Richie Serna, Finix CEO.
  • Similarly, Visa, Mastercard, Discover, and American Express certified Finix as a processor thanks to Finix's payments expertise and industry-leading technology.

FPF Report: Not-So-Standard Clauses – An Examination of Three Regional Contractual Frameworks for International Data Transfers

Retrieved on: 
Thursday, March 30, 2023

FPF Report: Not-So-Standard Clauses – An Examination of Three Regional Contractual Frameworks for International Data Transfers

Key Points: 
  • FPF Report: Not-So-Standard Clauses – An Examination of Three Regional Contractual Frameworks for International Data Transfers
    On March 30, the Future of Privacy Forum launched a new report comparing three regional model contractual frameworks for cross-border data transfers.
  • The report compares the EU’s Standard Contractual Clauses (SCCs), the ASEAN Model Contractual Clauses (MCCs), and the Iberoamerican Network’s Model Transfer Agreement (MTA).
  • International transfers of personal information are an increasingly contentious space in the privacy and data protection world.
  • Exceptions to those restrictions go hand-in-hand with those generalized restrictions on cross-border data transfers; in that context, pre-approved contractual frameworks between transferor and transferee have emerged as critical components of the modern cross-border data transfer environment.

Hillstream BioPharma Signs an Exclusive Option Agreement to Advance Next-Generation Anti-MUC1-C Agents for Drug Resistant Cancers

Retrieved on: 
Tuesday, January 31, 2023

BRIDGEWATER, N.J., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream”, or the “Company”), a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, today announced signing an exclusive option agreement with Dana-Farber Cancer Institute to license technology targeting the MUC1-C oncoprotein.

Key Points: 
  • The MUC1 gene was identified by Dr. Donald Kufe, Distinguished Physician and Researcher at Dana-Farber and based on its overexpression in human cancers.
  • Dr. Kufe’s long-standing work has supported the premise that prolonged activation of MUC1-C in settings of chronic inflammation promotes cancer.
  • “We look forward to this unique opportunity to work with Dr. Kufe and Dana-Farber,” said Randy Milby, CEO of Hillstream.
  • “This agreement allows Hillstream to leverage our Quatramer platform to advance anti-MUC1-C agents targeting CSCs for the treatment of highly aggressive tumors, which represents a major unmet need for patients.”

Orolia Defense & Security to Deliver Second-Generation Beacons to US Army

Retrieved on: 
Tuesday, October 4, 2022

ROCHESTER, N.Y., Oct. 4, 2022 /PRNewswire/ -- Orolia Defense and Security has received initial production authorization to provide PRSS1b Personnel Recovery Devices to the U.S. Army, with shipment beginning in September 2022. The order will fulfill the first contract line item (CLIN) complying with the current IDIQ (Indefinite Delivery/Indefinite Quantity). Orolia's PRSS1b PRD will be the first device of its kind to provide second-generation Cospas-Sarsat signaling that delivers faster and greater location accuracy than any other previously fielded tactical location device.

Key Points: 
  • Following its successful demonstration of second-generation signaling in October 2022 , Orolia Defense & Security is expected to be the first to receive Cospas-Sarsat certification.
  • Orolia Defense & Security looks forward to the future in fielding this capability to the Army and other services within the Department of Defense."
  • Orolia Defense & Security provides Resilient PNT solutions and custom engineering services to U.S. Government agencies, defense organizations and their contractors.
  • www.OroliaDS.com
    Orolia Defense & Security operates as a proxy-regulated company and wholly owned subsidiary of Orolia.

Switchgear Market Revenue To Cross $157,045.5 Million by 2030, says P&S Intelligence

Retrieved on: 
Friday, June 17, 2022

NEW YORK, June 17, 2022 /PRNewswire/ --According to the market research report published by P&S Intelligence, the switchgear market was valued at $93,432.6 million in the year 2021, and it will propel at a growth rate of approximately 6%, to reach $157,045.5 million by 2030.

Key Points: 
  • NEW YORK, June 17, 2022 /PRNewswire/ --According to the market research report published by P&S Intelligence, the switchgear market was valued at $93,432.6 million in the year 2021, and it will propel at a growth rate of approximately 6%, to reach $157,045.5 million by 2030.
  • Essentially, the market is progressing because of the increasing energy requirement in emerging and advanced economies, along with technological enhancements and the acceptance of computerization.
  • The APAC region had the largest share in the switchgear market, of approximately 45%, in the year 2021.
  • The share of low-voltage switchgear was the largest in the switchgear market in the year 2021, and its sales value will reach $85 billion by the year 2030.